Trimacare 80 Tablets for Dogs

Negara: Inggris

Bahasa: Inggris

Sumber: VMD (Veterinary Medicines Directorate)

Bahan aktif:

Sulfadiazine, Trimethoprim

Tersedia dari:

Norbrook Laboratories Limited

Kode ATC:

QJ01EW10

INN (Nama Internasional):

Sulfadiazine, Trimethoprim

Bentuk farmasi:

Tablet

Jenis Resep:

POM-V - Prescription Only Medicine – Veterinarian

Kelompok Terapi:

Dogs

Area terapi:

Antimicrobial

Status otorisasi:

Expired

Tanggal Otorisasi:

1998-01-21

Karakteristik produk

Revised 14 October 2008
AN: 00051/2008
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Trimacare 80 Tablets for Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Each tablet contains:
Trimethoprim 80 mg
Sulfadiazine 400 mg.
EXCIPIENTS:
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Tablet
White circular uncoated tablets scored on one side.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
When susceptible organisms are present the combination may be
effective in
treating the following conditions: alimentary tract infections,
respiratory and
urogenital infections, skin and wound infections and eye and ear
infections.
4.3
CONTRA-INDICATIONS
Not suitable for use in cats.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
No special warnings.
Revised 14 October 2008
AN: 00051/2008
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Wherever
possible,
use
of
Trimacare
should
be
based
on
suceptability
testing.
Not to be used in cases of hepatic or renal impairment, or blood
dyscrasia.
Maintain adequate fluid intake during treatment.
SPECIAL
PRECAUTIONS
TO
BE
TAKEN
BY
THE
PERSON
ADMINISTERING
THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Take care to avoid skin contact.
Wash hands after use.
Sulphonamides
may
cause
hypersensitivty
(allergy)
following
injection,
inhalation, ingestion or skin contact. Hypersensitivity to
sulphonamides may
lead to cross reactions with other antibiotics. Allergic reactions to
these
subatances may occasionally be serious.
1. Do not handle this product if you know you are sensitive to
sulphonamides.
2. If you develop symptoms following exposure such as a skin rash, you
should seek medical advice and show the doctor this warning.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
A low incidence of polyarthropathy and Keratoconjunctivitis Sicca (Dry
Eye)
has
been
reported
in
dogs
following
oral
administration
of
potentiated
sulphonamides. If either of these cond